Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
copper (cu-7) (1 trial)
copper gluconate (1 trial)
disulfiram (antabuse) (1 trial)
Prostatic Neoplasms (Phase 1)
Trials (1 total)
Trial APIs (3 total)